Cyted Health
PrivateLast Round
Series B
Aug 30, 2025
Total Funding Raised
$70.54M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cyted Health is a life sciences company that provides a non-endoscopic diagnostic platform and artificial intelligence-driven pathology services for the early detection of gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyted Health Comparables
Compare Cyted Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PAVmed Inc. | 78% | |
| EnteroTrack | 67% | |
| CDx Diagnostics | 65% |
Cyted Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 30, 2025 | ||||
| Grant | Feb 19, 2025 | ||||
| VC Round | May 17, 2023 | ||||
| Series A | May 17, 2023 | ||||
| Seed | Feb 1, 2020 | ||||
VC Round | Feb 1, 2020 |
Key People
Founding team and executive leadership
Cyted Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Seed |
| EQT Life Sciences | Series B |
| SBRI Healthcare | VC Round |
| BGF | Series B, VC Round, Series A |
| SBRI Centre of Excellence | Grant |
| British Business Bank | Series B |
| Morningside Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 25, 2026
US molecular diagnostic test in final validation and early commercialization.
- Apr 25, 2026
Diagnostic solutions integrated into NHS pathways across UK sites.
Recent news
Latest coverage and updates
- attends_eventOct 13, 2026
Cyted Ltd. attends ACG Annual Scientific Meeting in Tennessee, where late-breaking DETECT-ME data on the EndoSign biomarker test suggest that minimally invasive screening could expand detection among at-risk individuals and help reduce esophageal adenocarcinoma mortality.
- hiresSep 29, 2026
Cyted Ltd. appoints Thomas West as chair of its Board of Directors on Sep 29th '26, succeeding Gail Marcus and also adding him as a non-executive director.
- hiresSep 29, 2026
Cyted Ltd. appointed Tom as Chair and Robert as a Non-Executive Director, strengthening its Board for its next phase of growth.
- hiresSep 29, 2026
Cyted Ltd. appoints Thomas West as Chair of its Board of Directors and Non-Executive Director on Sep 29th '26, in the United Kingdom and Delaware, to support commercial growth across the US and UK.
- hiresSep 29, 2026
Cyted Ltd. appointed Robert Epstein as a Non-Executive Director in Delaware and the United Kingdom on Sep 29th '26 to support its continued commercial growth across the US and UK.
Cyted Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cyted Health's valuation, stock price, and market status.
Is Cyted Health a public or private company?
Cyted Health is a private company.
What is the current stock price of Cyted Health?
Cyted Health is a private company, so its shares have no public market price. Caplight tracks Cyted Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cyted Health worth (valuation)?
Valuation information for Cyted Health is not publicly available.
Can I buy Cyted Health stock?
Cyted Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cyted Health's last funding round?
Cyted Health's most recent funding round was Series B on August 30, 2025.
Who are the main investors in Cyted Health?
Key investors in Cyted Health include EQT Life Sciences, BGF, British Business Bank, Morningside Ventures, Advent Life Sciences.
Will Cyted Health IPO soon?
No public IPO plans have been announced for Cyted Health.
How can I track Cyted Health secondary market activity?
Caplight tracks bids, offers, and trades in Cyted Health's shares on secondary markets.